Structural basis of omalizumab therapy and omalizumab-mediated IgE exchangePennington, Luke F.; Tarchevskaya, Svetlana; Brigger, Daniel; Sathiyamoorthy, Karthik; Graham, Michelle T.; Nadeau, Kari Christine; Eggel, Alexander; Jardetzky, Theodore S. · Nature Communications · 2016

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma RegistrySnelder, S. M.; Weersink, E. J. M.; Braunstahl, G. J. · Allergy, Asthma & Clinical Immunology · 2017

P212 A real-world assessment of omalizumab treatment patterns in asthma patients newly treated with omalizumabKe, X.; Kavati, A.; Wertz, D.; Huang, Q.; Wang, L.; Willey, V.; Stephenson, J.; Ortiz, B.; Panettieri, R.; Corren, J. · Annals of Allergy, Asthma & Immunology · 2017

Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe AsthmaÖzgür, Eylem Sercan; Özge, Cengiz; Ïlvan, Ahmet; Naycı, Sibel Atış · Journal of Asthma · 2013

Induction de tolérance à l’alpha-gal sous omalizumab : étape 1 : suivi des TAB après omalizumabNouar, D.; Lemoine, R.; Carré-Faure, M.C.; Cottet, J.; Hoarau, C. · Revue Française d'Allergologie · 2018

Therapeutic switch from omalizumab to mepolizumab in patients with uncontrolled severe eosinophilic asthma: treatment effect by prior omalizumab treatment durationAlbers, Frank; Liu, Mark C.; Chipps, Bradley E.; Chapman, Kenneth R.; Muñoz, Xavier; Bergna, Miguel; Devouassoux, Gilles; Azmi, Jay; Price, Robert; Galkin, Dmitry · Journal of Allergy and Clinical Immunology · 2019

Omalizumab bij astmaP. L. B. Bruijnzeel · 2007

Failure of omalizumab in cholinergic urticariaR. A. Sabroe · 2010

Biperiden/trihexyphenidylReactions Weekly · 1995

NitrendipineReactions Weekly · 2003

ScopolamineReactions Weekly · 2007

ScopolamineReactions Weekly · 2012

ScopolamineReactions Weekly · 2009

Centella asiaticaReactions Weekly · 2011

Daunorubicin/mitoxantroneReactions Weekly · 2007

AnthracyclinesReactions Weekly · 1991